Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Results of the ORBITA study found no difference in exercise time after six weeks in patients with stable angina who received percutaneous coronary intervention (PCI) versus a placebo treatment. TCT 2017
Feature | Cath Lab

November 6, 2017 โ€“ Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found no ...

Home November 06, 2017
Home
News | Heart Valve Technology

November 6, 2017 โ€” One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System ...

Home November 06, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 6, 2017 โ€” ย The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months ...

Home November 06, 2017
Home
News | FFR Technologies

November 6, 2017 โ€” Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 6, 2017 โ€” Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...

Home November 06, 2017
Home
News | Stents Drug Eluting

November 3, 2017 โ€” Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical ...

Home November 03, 2017
Home
News | Antiplatelet and Anticoagulation Therapies

November 3, 2017 โ€” A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests statins are ...

Home November 03, 2017
Home
The Watchman LAA occluder PREVAIL Trial 5-year results were presented at the 2017 TCT meeting.
Feature | Atrial Fibrillation

November 2, 2017 โ€“ Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the ...

Home November 02, 2017
Home
The B. Braun Sequent Please drug-eluting balloon.
Feature | Drug-Eluting Balloons

November 2, 2017 โ€” The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug ...

Home November 02, 2017
Home
News | Chronic Total Occlusion (CTO)

November 2, 2017 โ€” Crossing the occlusion with a guidewire is often the most challenging part of chronic total occlusion ...

Home November 02, 2017
Home
News | Stents Drug Eluting

November 1, 2017 โ€” OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the ...

Home November 01, 2017
Home
News | Stents Bifurcation

November 1, 2017 โ€” The double kissing (DK) crush two-stent technique was associated with a lower rate of target lesion ...

Home November 01, 2017
Home
News | Heart Valve Technology

November 1, 2017 โ€” Analysis of the PARTNER 2A trial and the SAPIEN-3 Intermediate Risk registry found transcatheter ...

Home November 01, 2017
Home
News | Cath Lab

November 1, 2017 โ€” Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found an initial strategy ...

Home November 01, 2017
Home
News | Embolic Protection Devices

October 31, 2017 โ€” The VAMPIRE 3 study evaluated if the selective use of distal filter protection might decrease the ...

Home October 31, 2017
Home
Subscribe Now